TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Biosort AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,572
|
5,600
|
6,620 |
| Financial expenses |
1
|
3
|
4 |
| Earnings before taxes |
-1,114
|
455
|
541 |
| Total assets |
3,007
|
4,383
|
4,742 |
| Current assets |
1,373
|
3,906
|
4,484 |
| Current liabilities |
499
|
599
|
1,119 |
| Equity capital |
1,886
|
3,154
|
2,957 |
| - share capital |
297
|
313
|
335 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
62.7%
|
72.0%
|
62.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-70.9%
|
8.1%
|
8.2% |
| Return on assets (ROA) |
-37.0%
|
10.4%
|
11.5% |
| Current ratio |
275.2%
|
652.1%
|
400.7% |
| Return on equity (ROE) |
-59.1%
|
14.4%
|
18.3% |
| Change turnover |
-3,741
|
-600
|
2,060 |
| Change turnover % |
-70%
|
-10%
|
45% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.